Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer

Inclusion Criteria: * Male or female who is at or above the age of consent * Histologically confirmed original diagnosis of lung cancer * Life expectancy greater than 12 months * ECOG performance status 0, 1, or 2 at screening * Female subjects who agree to practice two effective methods of contraception from the time of signing the informed consent form through one month after the last dose of study drug * Male subjects who agree to practice effective barrier contraception during the entire study drug period and through one month after the last dose of study drug Exclusion Criteria: * Extra-thoracic lung cancer progression * Any active malignancies * Any uncontrolled or major organ dysfunction * Any past or current radiation or systemic therapies for the treatment of lung cancer * Known HIV infection or other immunosuppressive disorder * Concurrently participating in another study with an investigational immunotherapy or have received investigational immunotherapy within 3 months prior to screening